LOGOLOGOLOGOLOGO
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Impact of the EU’s General Pharmaceutical Legislation on Europe’s innovation ecosystem and biotechnology companies
      • Patient BioForum
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

US: National Security Commission on Emerging Biotechnology Interim Report

01/12/2023

POLICY DOCUMENT

USA, December 2023 - The National Security Commission on Emerging Biotechnology aims to explore "the opportunities and challenges facing the United States at the intersection of national security and emerging biotechnology" and through the Interim Report share findings and research to support comprehensive policy recommendations to be issued in 2024.

Source: National Security Commission on Emerging Biotechnology.

US: National Security Commission on Emerging Biotechnology Interim Report

Download

Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

14/10/2024

Feedstock: The building blocks of EU’s sustainability and resilience

Read more
25/09/2024

EuropaBio joins the European APPROVALS project

Read more
24/07/2024

PRIMED 2nd General Assembly

Read more

Important links

  • EuropaBio’s Vision for a Bold EU Biotech Act
  • The EU Biotech Act – EuropaBio Vision Paper

Categories in our Newsroom

EBIO-white
EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.
Contact us
Extra links
Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom
Become a member
Media pack
© 2024 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.